Morningside is a Boston-based investment firm founded in 1986 as a family office for the Chan family. It makes venture capital investments in companies with novel science and technology, with deep expertise in life sciences, digital health, artificial intelligence, materials, and technology. The firm takes a long-term approach to building companies and emphasizes ethical conduct. In addition to its investment activities, Morningside supports charitable initiatives in education, research and healthcare, including collaborations with Harvard T.H. Chan School of Public Health, UMass Chan Medical School, and the MIT Morningside Academy for Design.

UNC Kenan-Flagler Private Equity Fund is a student-run private equity fund affiliated with the University of North Carolina at Chapel Hill's Kenan-Flagler Business School. Founded in 2007 and based in Chapel Hill, North Carolina, it engages in private equity and venture capital activities across early and late stages, buyouts, growth capital, mezzanine financing, and real estate investments. The fund targets portfolio company investments of roughly $0.1 million to $0.15 million with enterprise values between $20 million and $125 million and co-invests with partner private investment firms. Operating in an educational setting, it aims to deliver real returns for investors while providing students with hands-on investment experience.

Cool Japan Fund is an investment firm established in 2013 and based in Tokyo, Japan. As a public-private fund, it provides risk capital to companies across media and content, food and services, and fashion and lifestyle, with the aim of promoting overseas demand for high-quality Japanese products and services and supporting international expansion of Japanese brands.

Incubate Fund is a seed and early-stage venture capital firm founded in 2010 and based in Tokyo, Japan, with an office in Singapore, that backs technology startups across Asia and North America. It concentrates on providing initial capital to entrepreneurs building software, platforms and digital services in sectors such as media, entertainment, gaming, online commerce, logistics, medical, financial services, real estate and housing, with a preference for mobile, social and web-based offerings. The firm has built a portfolio of over 300 companies in Asia and has helped portfolio firms reach public markets or achieve exits through M&A since its inception, reflecting an active role in funding and supporting growth-oriented ventures. Through its international footprint and early-stage focus, it supports founders through initial rounds and strategic guidance to accelerate development and scale.

Venrock is a Palo Alto-based venture capital firm founded in 1969 as the venture capital arm of the Rockefeller family. It concentrates on seed and early-stage technology and healthcare investments and has backed landmark companies such as Apple Computer, Intel, Illumina, Gilead Sciences, Athenahealth, DoubleClick, Nest, SlideShare, and Tudou. The firm manages multiple funds and maintains a US-focused investment approach, supporting entrepreneurs across information technology, life sciences, and related sectors throughout their growth journey.

Cenova Capital is a Shanghai-based venture capital firm specializing in late-stage and growth investments in China’s life sciences and healthcare sectors. Founded in 2010, it backs companies across pharmaceuticals, biotechnology, medical devices, diagnostics, healthcare services, and digital health, including health tech driven by artificial intelligence and big data. The firm has developed multiple funds to support early and expansion opportunities and has invested in a broad portfolio of healthcare services, medical products, and digital health ventures. Cenova targets opportunities that advance China’s healthcare system toward greater efficiency and market orientation, partnering with domestic and international institutional investors to support innovative companies at scale.

Samsara BioCapital is a Palo Alto-based venture capital firm founded in 2016 that concentrates on healthcare and biotechnology investments, including pharmaceuticals, oncology, and life sciences companies across the United States. The firm typically acts as a principal investor and has been described as supporting biotech innovation and partnering with entrepreneurs to advance new therapies; it is also described as providing investment advisory services to help entrepreneurs develop their ideas into successful companies.

Versant Ventures is a healthcare-focused venture capital firm founded in 1999 and based in San Francisco, with offices in Canada, the United States and Europe. The firm invests across the healthcare sector at all stages, with an emphasis on discovery and development of novel therapeutics, and portfolios spanning biotechnology, pharmaceuticals, life sciences, healthcare devices and healthtech. Versant combines deep investment, operating and scientific expertise to support entrepreneurs through hands-on company building. It has backed more than 65 portfolio companies that have achieved acquisitions or IPOs.

Pivotal bioVenture Partners is a San Francisco-based venture capital firm focused on life sciences and therapeutic devices. Founded in 2016, it backs early- and later-stage biotechnology companies across North America and Europe, supporting product development from inception through clinical advancement. The firm seeks opportunities in therapeutics, medical devices, and related life science platforms, bringing venture experience and scientific insight to help entrepreneurs translate innovative ideas into marketable solutions.

Frazier Healthcare Partners is a Seattle-based investment firm founded in 1991 that specializes in healthcare. It provides growth capital and venture investments to healthcare companies across the United States, Canada and Europe, spanning healthcare services, medical devices, pharmaceuticals and biotechnology, life sciences, oncology and wellness. The firm maintains dedicated Growth Buyout and Life Sciences teams and takes an active, hands-on approach to building portfolio companies through its network of healthcare executives, advisers and industry experts. It funds companies at multiple stages, from early venture to growth equity, and seeks to help them scale through strategic guidance, operational support and capital optimization.

Inflexion Partners is a venture capital firm based in Orlando, Florida, with additional offices in Tampa and Gainesville. Founded in 2003, it focuses on seed and early-stage investments in life sciences, software, and communications sectors. The firm typically invests between 100,000 and 1,000,000 and prefers to syndicate with angels, management, and other funds, often acting as lead or co-lead investor, and it seeks board seats on portfolio companies. It concentrates on opportunities in Florida and the Southeast United States.

Kronos provides workforce management solutions that help organizations control labor costs, minimize compliance risk, and improve workforce productivity. Its applications are designed for businesses, healthcare providers, educational institutions, and government agencies of all sizes. The company was founded in 1977 and is headquartered in Chelmsford, Massachusetts.

UOB Venture Management is the investment arm of United Overseas Bank, focusing on growth-stage opportunities in Southeast Asia and Greater China. Founded in 1992 and headquartered in Singapore with offices in Shanghai, Beijing, and Jakarta, the firm backs expansion-ready companies across energy, consumer, environmental technology, industrials, healthcare, agriculture, and technology. It typically makes investments up to USD 25 million per deal and leverages UOB's regional footprint to support portfolio companies as they scale in ASEAN and China.

Empower Investment is a venture capital firm founded in 2012 and headquartered in Shanghai, China. It backs early-stage ventures, mid-stage growth companies, and public-market securities, with a global reach that includes China, the United States, India, South Korea, Vietnam, and Hong Kong. The firm maintains branch offices in Beijing, Shenzhen, Hangzhou, and Chengdu and has invested in more than 150 high-tech and high-growth companies across sectors such as internet, artificial intelligence, big data, automation and robotics, fintech, cultural and creative industries, advanced materials, and healthcare. Its team combines expertise in deep technologies and financial services, including backgrounds in computer science, electronic engineering, materials science, auditing, and investment banking, with experienced entrepreneurs among its members. Empower Investment seeks to partner with visionary and determined entrepreneurs, aiming to build a bright future together.

Vectr Ventures is a global early-stage venture capital firm headquartered in Hong Kong, founded in 2014. It backs technology startups and supports founders through capital, creation and partnerships to develop transformative products and grow into Asian markets. The firm has a fintech-focused affiliate, Vectr Fintech Partners, and pursues opportunities across infrastructure, private capital markets and deep tech.

Oriza Holdings is a Chinese asset management and investment firm based in Suzhou. It manages equity and debt financing and operates multiple investment arms that provide funding to seed through growth-stage companies across industrials, healthcare, semiconductors, and information technology, with a focus on opportunities in Southeast Asia. The firm coordinates investment resources with industrial assets through its platform Oriza Prior, aiming to enhance value by aligning capital with strategic assets and driving operational synergies for portfolio companies.

SBI Ven Capital is the venture capital arm of SBI Holdings, based in Singapore. Founded in 2007, it targets investments in financial services and technology sectors across Asia.

Polaris Partners is a Boston-based venture capital firm with offices in Boston and San Francisco that backs technology and life sciences companies across the United States and Europe. Founded in 1996, the firm partners with repeat entrepreneurs to support companies through multiple stages, from inception to growth, with a focus on software, healthcare information technology, digital health, life sciences, biotechnology, pharmaceuticals, genomics, and related sectors. Its investments span the business-to-business and business-to-consumer markets, software as a service, and other technology-enabled solutions, aiming to build durable platform companies and address significant needs in healthcare and technology.

GGV Capital is a global venture capital firm that, as of March 2024, operates as two separate brands: Granite Asia, based in Singapore, which invests across the Asia-Pacific region including Southeast Asia, Japan, China, India, and Australia; and Notable Capital, based in Silicon Valley with offices in San Francisco and New York, which invests in the United States, Israel, Europe, and Latin America. Founded in 2000, the firm has a long track record of providing expansion and early-stage capital to technology companies in the United States and China, and it supports portfolio companies across software, IT, cloud, and related technology sectors.

Notable Capital is a U.S. venture capital firm that invests in early‑to‑growth stage companies in cloud infrastructure and business and consumer applications across the United States, Israel, Europe, Latin America, and select global opportunities. The firm partners with founders who pursue innovative ideas and champion causes, building remarkable companies. Its portfolio includes companies such as Airbnb, Block, HashiCorp, Slack, and Zendesk, among others.

F-Prime Capital is a venture capital investment firm based in Cambridge, Massachusetts. Founded in 1969 with roots in Fidelity Investments, it backs entrepreneurs across technology and life sciences, investing in sectors such as crypto, enterprise information technology, fintech, frontier technologies, health information technology and services, medtech and therapeutics, with a global reach across the Americas, Europe and Asia.